321 related articles for article (PubMed ID: 24662829)
1. A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis.
Subramanian M; Francis P; Bilke S; Li XL; Hara T; Lu X; Jones MF; Walker RL; Zhu Y; Pineda M; Lee C; Varanasi L; Yang Y; Martinez LA; Luo J; Ambs S; Sharma S; Wakefield LM; Meltzer PS; Lal A
Oncogene; 2015 Feb; 34(9):1094-104. PubMed ID: 24662829
[TBL] [Abstract][Full Text] [Related]
2. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.
Liu K; Ling S; Lin WC
Mol Cell Biol; 2011 Nov; 31(22):4464-81. PubMed ID: 21930790
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.
Sasaki Y; Tamura M; Takeda K; Ogi K; Nakagaki T; Koyama R; Idogawa M; Hiratsuka H; Tokino T
Oncotarget; 2016 Sep; 7(38):61426-61437. PubMed ID: 27556181
[TBL] [Abstract][Full Text] [Related]
4. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH
Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.
Li XL; Jones MF; Subramanian M; Lal A
FEBS Lett; 2014 Aug; 588(16):2610-5. PubMed ID: 24726728
[TBL] [Abstract][Full Text] [Related]
6. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
Boominathan L
Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome.
Neilsen PM; Noll JE; Suetani RJ; Schulz RB; Al-Ejeh F; Evdokiou A; Lane DP; Callen DF
Oncotarget; 2011 Dec; 2(12):1203-17. PubMed ID: 22203497
[TBL] [Abstract][Full Text] [Related]
8. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
9. p53 and its mutants in tumor cell migration and invasion.
Muller PA; Vousden KH; Norman JC
J Cell Biol; 2011 Jan; 192(2):209-18. PubMed ID: 21263025
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.
Neilsen PM; Noll JE; Mattiske S; Bracken CP; Gregory PA; Schulz RB; Lim SP; Kumar R; Suetani RJ; Goodall GJ; Callen DF
Oncogene; 2013 Jun; 32(24):2992-3000. PubMed ID: 22797073
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype.
Muller PA; Trinidad AG; Caswell PT; Norman JC; Vousden KH
J Biol Chem; 2014 Jan; 289(1):122-32. PubMed ID: 24220032
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.
Mandal CC; Ghosh-Choudhury N; Yoneda T; Choudhury GG; Ghosh-Choudhury N
J Biol Chem; 2011 Apr; 286(13):11314-27. PubMed ID: 21199873
[TBL] [Abstract][Full Text] [Related]
13. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.
Melino G
Cell Death Differ; 2011 Sep; 18(9):1487-99. PubMed ID: 21760596
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.
Arjonen A; Kaukonen R; Mattila E; Rouhi P; Högnäs G; Sihto H; Miller BW; Morton JP; Bucher E; Taimen P; Virtakoivu R; Cao Y; Sansom OJ; Joensuu H; Ivaska J
J Clin Invest; 2014 Mar; 124(3):1069-82. PubMed ID: 24487586
[TBL] [Abstract][Full Text] [Related]
15. Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells.
Boudreau HE; Casterline BW; Burke DJ; Leto TL
Br J Cancer; 2014 May; 110(10):2569-82. PubMed ID: 24714748
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
17. Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells.
Yang WH; Lan HY; Tai SK; Yang MH
Biochem Biophys Res Commun; 2013 Mar; 433(1):24-30. PubMed ID: 23454123
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
19. Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Li Y; Prives C
Oncogene; 2007 Apr; 26(15):2220-5. PubMed ID: 17401431
[TBL] [Abstract][Full Text] [Related]
20. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
